S4029Referred to Committee

A bill to reinforce the Foreign Corrupt Practices Act of 1977 by establishing a limitations period of 10 years for antibribery offenses, and for other purposes.

Introduced

In Committee

Passed One Chamber

Passed Both

Signed into Law

119th

Congress

2026-03-09

Introduced

Cosponsors

ⓘ

Type

Sponsor

Elizabeth Warren

Democrat · MA · Senator

Votes with party: 66.5% (319 recorded votes)

Full profile: /officials/W000817

Source: Congress.gov · FEC

Cosponsors (13)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on the Judiciary.

2026-03-09

Source: Congress.gov

Plain-English Summary

The government would set a 10-year time limit for prosecuting companies and individuals who bribe foreign officials to win business deals, meaning prosecutors would have a decade from when the offense occurs to bring charges. This change would strengthen enforcement of existing anti-bribery laws that prevent American businesses from paying off foreign government officials to gain unfair advantages in international deals. The bill affects multinational corporations, their executives, and federal prosecutors who investigate financial crimes overseas.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Finance and Financial Sector

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 4029 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 4029 To reinforce the Foreign Corrupt Practices Act of 1977 by establishing a limitations period of 10 years for antibribery offenses, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES March 9, 2026 Ms. Warren (for herself, Mr. Whitehouse, Mr. Kim, Mr. Durbin, Mrs. Shaheen, Mr. Coons, Mr. Welch, Mr. Blumenthal, Mr. King, Mr. Wyden, Mr. Schiff, Mr. Van Hollen, Ms. Duckworth, and Mr. Merkley) introduced the following bill; which was read twice and referred to the Committee on the Judiciary _______________________________________________________________________ A BILL To reinforce the Foreign Corrupt Practices Act of 1977 by establishing a limitations period of 10 years for antibribery offenses, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. LIMITATIONS FOR ANTIBRIBERY OFFENSES. (a) In General.--Notwithstanding section 3282(a) of title 18, United States Code, no person shall be prosecuted, tried, or punished for any offense under section 30A of the Securities Exchange Act of 1934 (15 U.S.C. 78dd-1) or section 104 or 104A of the Foreign Corrupt Practices Act of 1977 (15 U.S.C. 78dd-2, 78dd-3) unless the indictment is found or the information is instituted within 10 years next after such offense shall have been committed. (b) Applicability.--Subsection (a) shall not apply to any offense committed during the period ending on the date that is 5 years before the date of enactment of this Act. (c) Sunset.--This Act is effective beginning on the date of enactment of this Act and ending on the date that is 8 years after that date. <all>

Open clean-text view Read on Congress.gov →

Related legislation

Bills by the same sponsor or covering overlapping subjects.

S4648A bill to improve transparency with respect to foreign influence on Department of Defense contractors.
Referred to Committee · 2026-06-01
S4550Maternal Health Pandemic Response Act
Referred to Committee · 2026-05-18
SRES732A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Referred to Committee · 2026-05-14
S4509PBM Act
Referred to Committee · 2026-05-13